Cargando…

Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer

OBJECTIVE: Our purpose was to develop and verify an immune-related signature for predicting recurrence risk of patients with laryngeal cancer. METHODS: RNA-seq data of 51 recurrence and 81 non-recurrence laryngeal cancer samples were downloaded from TCGA database, as the training set. Microarray dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hang, Zhao, Xudong, Wang, Jin, Ji, Wenyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716380/ https://www.ncbi.nlm.nih.gov/pubmed/34976784 http://dx.doi.org/10.3389/fonc.2021.683915

Ejemplares similares

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma
por: Hong, Xiu, et al.
Publicado: (2023)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
por: Li, He, et al.
Publicado: (2022)

Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Liu, Yanqing, et al.
Publicado: (2022)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Du, Yi-Heng
Publicado: (2023)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2019)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Development of an Immune-Related Gene Signature for Prognosis in Melanoma
por: Zhang, Jia-An, et al.
Publicado: (2021)

Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma
por: Hou, Chen, et al.
Publicado: (2020)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
por: Li, Chun, et al.
Publicado: (2022)

Preoperative Clinical Characteristics Predict Recurrent Laryngeal Nerve Lymph Node Metastasis and Overall Survival in Esophageal Squamous Cell Carcinoma: A Retrospective Study With External Validation
por: Yan, Hao-Ji, et al.
Publicado: (2022)

Validation of internal reference genes for relative quantitation studies of gene expression in human laryngeal cancer
por: Wang, Xiaofeng, et al.
Publicado: (2016)

Long noncoding RNA LINC01638 contributes to laryngeal squamous cell cancer progression by modulating miR-523-5p/BATF3 axis
por: Zhang, Hang, et al.
Publicado: (2021)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma
por: Wang, Sheng, et al.
Publicado: (2021)

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients
por: Guo, Meiying, et al.
Publicado: (2020)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma
por: Zhao, Xudong, et al.
Publicado: (2018)

Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma
por: Ren, He, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer
por: Zhou, Leqi, et al.
Publicado: (2022)

Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer
por: Yuan, Yihang, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Preoperative Prediction of Lymph Node Metastasis in Lung Adenocarcinoma Based on Radiomics Signature and Deep Learning Signature
por: Ran, Jia, et al.
Publicado: (2021)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma
por: Wang, Cailian, et al.
Publicado: (2021)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors
por: Zhou, Jian-Guo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_444tmr37oo3nbd2keve65s8kol